Renee Dawn Sale, CRNA | |
5475 S 500 E, Ogden, UT 84405-6905 | |
(800) 880-3566 | |
(801) 733-5872 |
Full Name | Renee Dawn Sale |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 23 Years |
Location | 5475 S 500 E, Ogden, Utah |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356352520 | NPI | - | NPPES |
68295 | Other | UT | PEHP |
P00221106 | Other | UT | RAILROAD MEDICARE |
34988 | Other | UT | HEALTHY U |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 5784240-4406 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Peacehealth St John Medical Center | Longview, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Peacehealth | 5890689293 | 182 |
News Archive
An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.
Most people think that arthritis is an inevitable part of aging. Today, Jamieson Laboratories has introduced UC-II undenatured collagen, a formulation that will turn back the clock on joint pain by naturally promoting the restoration of cartilage and inhibiting its deterioration. This new anti-aging formula taken only once daily is proven to be twice as effective as other joint remedies.
German researchers have found strong evidence that attaining a higher level of education and spending more years in school are two factors associated with a greater prevalence and severity of nearsightedness, or myopia.
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.
Cardiovascular disease remains the leading cause of mortality in Europe, and World Health Organization (WHO) heart disease goals will not be achieved by 2025 unless urgent action is taken. That is the finding of a European Society of Cardiology (ESC) report published today.
› Verified 5 days ago
Entity Name | Peacehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134178999 PECOS PAC ID: 9739092065 Enrollment ID: O20031111000831 |
News Archive
An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.
Most people think that arthritis is an inevitable part of aging. Today, Jamieson Laboratories has introduced UC-II undenatured collagen, a formulation that will turn back the clock on joint pain by naturally promoting the restoration of cartilage and inhibiting its deterioration. This new anti-aging formula taken only once daily is proven to be twice as effective as other joint remedies.
German researchers have found strong evidence that attaining a higher level of education and spending more years in school are two factors associated with a greater prevalence and severity of nearsightedness, or myopia.
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.
Cardiovascular disease remains the leading cause of mortality in Europe, and World Health Organization (WHO) heart disease goals will not be achieved by 2025 unless urgent action is taken. That is the finding of a European Society of Cardiology (ESC) report published today.
› Verified 5 days ago
Entity Name | Peacehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720056187 PECOS PAC ID: 5890689293 Enrollment ID: O20040209000272 |
News Archive
An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.
Most people think that arthritis is an inevitable part of aging. Today, Jamieson Laboratories has introduced UC-II undenatured collagen, a formulation that will turn back the clock on joint pain by naturally promoting the restoration of cartilage and inhibiting its deterioration. This new anti-aging formula taken only once daily is proven to be twice as effective as other joint remedies.
German researchers have found strong evidence that attaining a higher level of education and spending more years in school are two factors associated with a greater prevalence and severity of nearsightedness, or myopia.
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.
Cardiovascular disease remains the leading cause of mortality in Europe, and World Health Organization (WHO) heart disease goals will not be achieved by 2025 unless urgent action is taken. That is the finding of a European Society of Cardiology (ESC) report published today.
› Verified 5 days ago
Entity Name | Anesthesia Associates Northwest Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548281751 PECOS PAC ID: 7618908484 Enrollment ID: O20161115001177 |
News Archive
An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.
Most people think that arthritis is an inevitable part of aging. Today, Jamieson Laboratories has introduced UC-II undenatured collagen, a formulation that will turn back the clock on joint pain by naturally promoting the restoration of cartilage and inhibiting its deterioration. This new anti-aging formula taken only once daily is proven to be twice as effective as other joint remedies.
German researchers have found strong evidence that attaining a higher level of education and spending more years in school are two factors associated with a greater prevalence and severity of nearsightedness, or myopia.
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.
Cardiovascular disease remains the leading cause of mortality in Europe, and World Health Organization (WHO) heart disease goals will not be achieved by 2025 unless urgent action is taken. That is the finding of a European Society of Cardiology (ESC) report published today.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Renee Dawn Sale, CRNA 2050 N 680 W, West Bountiful, UT 84087-1119 Ph: (801) 298-2792 | Renee Dawn Sale, CRNA 5475 S 500 E, Ogden, UT 84405-6905 Ph: (800) 880-3566 |
News Archive
An international public-private research team led by scientists at the Broad Institute of MIT and Harvard announced today the construction and availability of an extensive library of molecular reagents to silence most human and mouse genes.
Most people think that arthritis is an inevitable part of aging. Today, Jamieson Laboratories has introduced UC-II undenatured collagen, a formulation that will turn back the clock on joint pain by naturally promoting the restoration of cartilage and inhibiting its deterioration. This new anti-aging formula taken only once daily is proven to be twice as effective as other joint remedies.
German researchers have found strong evidence that attaining a higher level of education and spending more years in school are two factors associated with a greater prevalence and severity of nearsightedness, or myopia.
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.
Cardiovascular disease remains the leading cause of mortality in Europe, and World Health Organization (WHO) heart disease goals will not be achieved by 2025 unless urgent action is taken. That is the finding of a European Society of Cardiology (ESC) report published today.
› Verified 5 days ago
Jenny L Cole, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5475 S 500 E, Ogden, UT 84405 Phone: 800-880-3566 Fax: 801-733-5872 | |
Joseph Reyna, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5475 S 500 E, Ogden, UT 84405 Phone: 801-479-2468 Fax: 801-479-2936 | |
Krystal Mae Tipping, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S 1500 W, Ogden, UT 84404 Phone: 801-710-1161 | |
Layne B Croxford, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4364 Washington Blvd, Ogden, UT 84403 Phone: 801-479-4470 | |
Rebecca Jo Santek, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-727-2056 Fax: 770-701-6675 | |
Richard C Torman, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 5475 S 500 E, Ogden, UT 84405 Phone: 800-880-3566 Fax: 801-733-5872 | |
Rock E. Harper, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 5475 S 500 E, Ogden, UT 84405 Phone: 800-880-3566 Fax: 801-733-5872 |